Targeted Co-Delivery of Docetaxel and cMET siRNA for Treatment of Mucin1 Overexpressing Breast Cancer Cells

Naime Majidi Zolbanin ^1,2 , Reza Jafari ^3,4 , Jafar Majidi ^5,6 , Fatemeh Atyabi ^7,8 , Mehdi Yousefi ^5,6 , Farhad Jadidi-Niaragh ^5,6 , Leili Aghebati-Maleki ⁵ , Dariush Shanehbandi ⁵ , Mohammad-Sadegh Soltani Zangbar ⁶, Alireza Mohajjel Nayebi ^1,2

Cited by CrossRef: 19

1- Ashrafizadeh M, Zarrabi A, Hushmandi K, Hashemi F, Rahmani Moghadam E, Raei M, Kalantari M, Tavakol S, Mohammadinejad R, Najafi M, Tay F, Makvandi P. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Comb Sci. 2020;22(12):669 [Crossref]

2- Gayathri K, Bhaskaran M, Selvam C, Thilagavathi R. Nano formulation approaches for curcumin delivery- a review. Journal of Drug Delivery Science and Technology. 2023;82:104326 [Crossref]

3- Ding F, Fu J, Tao C, Yu Y, He X, Gao Y, Zhang Y. Recent Advances of Chitosan and its Derivatives in Biomedical Applications. CMC. 2020;27(18):3023 [Crossref]

4- Gamboa J, Lourenço P, Cruz C, Gallardo E. Aptamers for the Delivery of Plant-Based Compounds: A Review. Pharmaceutics. 2024;16(4):541 [Crossref]

5- Rafik S, Vaidya J, MacRobert A, Yaghini E. Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. JCM. 2023;12(7):2648 [Crossref]

6- Fu Z, Xiang J. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. IJMS. 2020;21(8):2793 [Crossref]

7- Gote V, Nookala A, Bolla P, Pal D. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. IJMS. 2021;22(9):4673 [Crossref]

8- Manoochehri H, Jalali A, Tanzadehpanah H, Taherkhani A, Najafi R. Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs. Colloids and Surfaces B: Biointerfaces. 2022;218:112714 [Crossref]

9- Afzal M, Afzal A, Alharbi K, Alruwaili N, Al-Abassi F, Al-Malki A, Kazmi I, Kumar V, Kamal M, Nadeem M, Aslam M, Anwar F. Nanomedicine in treatment of breast cancer – A challenge to conventional therapy. Seminars in Cancer Biology. 2021;69:279 [Crossref]

10- Mousazadeh H, Khorsandi M, Zarghami N. Stimulus-responsive nanocarrier from star-shaped polyethyleneimine-β-cyclodextrin coated mesoporous silica for targeted combination cancer therapy. Journal of Drug Delivery Science and Technology. 2023;88:104940 [Crossref]

11- Zafar A, Alruwaili N, Imam S, Alharbi K, Afzal M, Alotaibi N, Yasir M, Elmowafy M, Alshehri S. Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review. Journal of Drug Delivery Science and Technology. 2021;61:102198 [Crossref]

12- Dhanya C, Mary A, Madhavan M. Aptamer‐siRNA chimeras: Promising tools for targeting HER2 signaling in cancer. Chem Biol Drug Des. 2023;101(5):1162 [Crossref]

13- Shishparenok A, Furman V, Zhdanov D. DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors. Cancers. 2023;15(7):2151 [Crossref]

14- Dinis Ano Bom A, da Costa Neves P, Bonacossa de Almeida C, Silva D, Missailidis S. Aptamers as Delivery Agents of siRNA and Chimeric Formulations for the Treatment of Cancer. Pharmaceutics. 2019;11(12):684 [Crossref]

15- Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh S, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar A, Aref A, Samarghandian S. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomedicine & Pharmacotherapy. 2021;141:111824 [Crossref]

16- Bidar N, Darroudi M, Ebrahimzadeh A, Safdari M, de la Guardia M, Baradaran B, Goodarzi V, Oroojalian F, Mokhtarzadeh A. Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances. European Journal of Pharmacology. 2022;915:174639 [Crossref]

17- Manna S, Mahata R, Dey S, Das Chaudhuri A, Choudhury S. Multifunctional aptamer grafted targeted nano‐drugs execute molecular cross‐talks with cancer cells. Applied Research. 2024; [Crossref]

18- Pujol-Navarro N, Al Qaraghuli M, Kubiak-Ossowska K, Alsaadi M, Horne G, Soutar R, Paspali E, Ferro V, Williams M, Mulheran P. Multiple myeloma: therapeutic delivery of antibodies and aptamers. Therapeutic Delivery. 2021;12(10):705 [Crossref]